Genetic engineering of immunotoxins.
Youle
R J
RJ
Greenfield
L
L
Johnson
V G
VG
D001665:Binding Sites; D004167:Diphtheria Toxin / Q000235:genetics* / Q000378:metabolism / Q000494:pharmacology; D015195:Drug Design; D004355:Drug Stability; D066257:Heparin-binding EGF-like Growth Factor; D000922:Immunotoxins / Q000493:pharmacokinetics; D036341:Intercellular Signaling Peptides and Proteins; D015202:Protein Engineering; D011956:Receptors, Cell Surface; D011950:Receptors, Cholinergic / Q000378:metabolism; D011975:Receptors, Mitogen / Q000378:metabolism; D011994:Recombinant Proteins / Q000378:metabolism; D012276:Ricin / Q000235:genetics* / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology
D004167:Diphtheria Toxin; D066257:Heparin-binding EGF-like Growth Factor; D000922:Immunotoxins; D036341:Intercellular Signaling Peptides and Proteins; D011956:Receptors, Cell Surface; D011950:Receptors, Cholinergic; D011975:Receptors, Mitogen; D011994:Recombinant Proteins; C032650:Ricinus communis lectin receptor; D012276:Ricin